Cantor Fitzgerald Has Lowered Expectations for AvePoint (NASDAQ:AVPT) Stock Price

AvePoint (NASDAQ:AVPTGet Free Report) had its target price cut by equities research analysts at Cantor Fitzgerald from $18.00 to $15.00 in a research report issued on Friday,Benzinga reports. The brokerage presently has an “overweight” rating on the stock. Cantor Fitzgerald’s target price would suggest a potential upside of 39.15% from the stock’s current price.

Several other equities analysts have also recently weighed in on AVPT. DA Davidson cut their price objective on AvePoint from $20.00 to $18.00 and set a “buy” rating for the company in a research report on Thursday, February 19th. Stephens started coverage on shares of AvePoint in a research note on Monday, December 29th. They set an “overweight” rating and a $18.00 price target on the stock. Wall Street Zen raised shares of AvePoint from a “hold” rating to a “buy” rating in a report on Sunday, November 9th. B. Riley Financial decreased their target price on shares of AvePoint from $25.00 to $22.00 and set a “buy” rating on the stock in a research report on Monday, February 2nd. Finally, Citigroup lowered their target price on shares of AvePoint from $16.00 to $15.00 and set a “neutral” rating on the stock in a research note on Tuesday, January 13th. Eleven analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $17.28.

Read Our Latest Report on AVPT

AvePoint Trading Up 3.9%

Shares of AvePoint stock opened at $10.78 on Friday. The firm has a fifty day simple moving average of $12.13 and a 200-day simple moving average of $13.66. The stock has a market capitalization of $2.33 billion, a price-to-earnings ratio of 67.38 and a beta of 1.09. AvePoint has a 1-year low of $9.85 and a 1-year high of $20.25.

AvePoint (NASDAQ:AVPTGet Free Report) last announced its earnings results on Thursday, February 26th. The company reported $0.07 EPS for the quarter, missing the consensus estimate of $0.09 by ($0.02). The firm had revenue of $114.69 million during the quarter, compared to the consensus estimate of $110.94 million. AvePoint had a return on equity of 8.46% and a net margin of 8.34%. As a group, research analysts predict that AvePoint will post -0.03 earnings per share for the current year.

Insider Buying and Selling at AvePoint

In other news, Chairman Xunkai Gong sold 32,002 shares of the firm’s stock in a transaction on Monday, January 12th. The stock was sold at an average price of $13.66, for a total value of $437,147.32. Following the transaction, the chairman directly owned 14,948,666 shares in the company, valued at $204,198,777.56. This trade represents a 0.21% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 26.19% of the stock is currently owned by company insiders.

Hedge Funds Weigh In On AvePoint

A number of hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Morgan Stanley grew its position in shares of AvePoint by 372.6% during the 4th quarter. Morgan Stanley now owns 7,871,282 shares of the company’s stock worth $109,332,000 after buying an additional 6,205,829 shares during the period. Invesco Ltd. grew its holdings in AvePoint by 218.0% during the second quarter. Invesco Ltd. now owns 5,335,882 shares of the company’s stock valued at $103,036,000 after purchasing an additional 3,657,692 shares during the period. Parsifal Capital Management LP grew its holdings in AvePoint by 61.2% during the third quarter. Parsifal Capital Management LP now owns 8,522,740 shares of the company’s stock valued at $127,926,000 after purchasing an additional 3,235,384 shares during the period. Healthcare of Ontario Pension Plan Trust Fund increased its stake in AvePoint by 620.9% in the fourth quarter. Healthcare of Ontario Pension Plan Trust Fund now owns 2,140,572 shares of the company’s stock valued at $29,733,000 after purchasing an additional 1,843,641 shares in the last quarter. Finally, Prudential PLC bought a new stake in AvePoint in the third quarter valued at approximately $26,824,000. Institutional investors own 44.49% of the company’s stock.

Trending Headlines about AvePoint

Here are the key news stories impacting AvePoint this week:

AvePoint Company Profile

(Get Free Report)

AvePoint, Inc (NASDAQ:AVPT) is a leading software provider specializing in data management, governance, and compliance solutions for Microsoft 365 and related cloud platforms. Founded in 2001 and headquartered in Jersey City, New Jersey, the company offers a comprehensive suite of cloud-based and on-premises tools designed to help organizations migrate, manage, and protect their collaboration data. AvePoint’s flagship Cloud Platform delivers backup, governance, reporting, and migration services for SharePoint, Teams, Exchange, OneDrive, and Salesforce environments.

With a customer base spanning thousands of organizations across more than 100 countries, AvePoint serves enterprises, government agencies, and educational institutions seeking to ensure data security, regulatory compliance, and operational resilience.

Recommended Stories

Analyst Recommendations for AvePoint (NASDAQ:AVPT)

Receive News & Ratings for AvePoint Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AvePoint and related companies with MarketBeat.com's FREE daily email newsletter.